Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLESS: Butylphthalide in minor acute ischemic stroke
NCT07230587Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of butylphthalide in ischemic stroke, sponsored by Peking Union Medical College Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07230587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230587.